Literature DB >> 24725714

Tetralogy of fallot and pulmonary valve replacement: timing and techniques in the asymptomatic patient.

Stephanie Fuller1.   

Abstract

An increasing number of survivors of congenital heart disease will require repeat surgical intervention. In the tetralogy of Fallot population, the primary indication is for pulmonary valve replacement secondary to pulmonary regurgitation. Although pulmonary valve disruption during repair is initially well tolerated, by the second decade following repair, patients develop increased right ventricular size with potentially decreased function. It is now well accepted that patients experiencing symptoms of heart failure secondary to chronic pulmonary insufficiency undergo pulmonary valve replacement. However, in the asymptomatic population, indications and timing of valve replacement are less clear. This article examines the current literature and presents guidelines regarding pulmonary valve replacement in the asymptomatic patient. Also, in the current era of percutaneous valve replacement, certain technical considerations should be given toward valve replacement and are discussed as well.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24725714     DOI: 10.1053/j.pcsu.2014.01.012

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu        ISSN: 1092-9126


  3 in total

1.  Repair with a pulmonary neovalve in tetralogy of Fallot: does this avoid ventricular dysfunction?

Authors:  Albert Franz Guerrero; Ivonne Gisel Pineda-Rodríguez; Andres Mauricio Palacio; Carlos Eduardo Obando; Tomas Chalela; Jaime Camacho; Carlos Villa; Juan Pablo Umaña; Nestor Fernando Sandoval-Reyes
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-07-09

2.  Whole Exome Sequencing Reveals the Major Genetic Contributors to Nonsyndromic Tetralogy of Fallot.

Authors:  Donna J Page; Matthieu J Miossec; Simon G Williams; Richard M Monaghan; Elisavet Fotiou; Heather J Cordell; Louise Sutcliffe; Ana Topf; Mathieu Bourgey; Guillaume Bourque; Robert Eveleigh; Sally L Dunwoodie; David S Winlaw; Shoumo Bhattacharya; Jeroen Breckpot; Koenraad Devriendt; Marc Gewillig; J David Brook; Kerry J Setchfield; Frances A Bu'Lock; John O'Sullivan; Graham Stuart; Connie R Bezzina; Barbara J M Mulder; Alex V Postma; James R Bentham; Martin Baron; Sanjeev S Bhaskar; Graeme C Black; William G Newman; Kathryn E Hentges; G Mark Lathrop; Mauro Santibanez-Koref; Bernard D Keavney
Journal:  Circ Res       Date:  2019-02-15       Impact factor: 17.367

3.  Long-Term Comparison Between Pulmonary Homograft Versus Bioprosthesis for Pulmonary Valve Replacement in Tetralogy of Fallot.

Authors:  Lucia Cocomello; Marco Meloni; Filippo Rapetto; Mai Baquedano; Maria Victoria Ordoñez; Giovanni Biglino; Chiara Bucciarelli-Ducci; Andrew Parry; Serban Stoica; Massimo Caputo
Journal:  J Am Heart Assoc       Date:  2019-12-16       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.